Travere Therapeutics, Inc. · NASDAQ:TVTX
Meckler Jeffrey A sold 20,000 Travere Therapeutics, Inc. shares (Form 4)
Traded Sep 10, 2026 · Filed Sep 11, 2026
On Sep 10, 2026, Meckler Jeffrey A (Director) sold 20,000 Travere Therapeutics, Inc. shares at an average US$67.30 for US$1.35M under a trading plan, leaving 91,500 shares. Filed Sep 11, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$67.30 average (US$65.39 to US$68.09)
- Value
- US$1.35M
- Holding after
- 91,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | Option exercise | 10,000 | US$17.44 | 101,500 | Direct |
| Sep 10, 2026 | Common Stock | Option exercise | 10,000 | US$26.52 | 111,500 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 1,700 | US$65.39 | 109,800 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 1,200 | US$66.15 | 108,600 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 14,000 | US$67.46 | 94,600 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 3,100 | US$68.09 | 91,500 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Meckler Jeffrey A
- Travere Therapeutics, Inc. shareholders
- Form 4 · Meckler Jeffrey A · May 21, 2026
- Form 4 · Meckler Jeffrey A · May 6, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026